Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 8NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 34Paclitaxel 29Radiotherapy 23Cisplatin 23Docetaxel 18Pemetrexed 14Gemcitabine 14Radiosurgery 10Bevacizumab 9Magnetic Resonance Spectroscopy 7Etoposide 7Ramucirumab 6Erlotinib Hydrochloride 6Cetuximab 6Specimen Handling 5Gene Expression Profiling 5durvalumab 4cediranib 4Vinorelbine 4Polymerase Chain Reaction 4Amplified Fragment Length Polymorphism Analysis 4pembrolizumab 3cemiplimab 3Watchful Waiting 3Taxes 3Surgical Procedures, Operative 3Radiotherapy, Conformal 3Psychiatric Rehabilitation 3Neoadjuvant Therapy 3Fluorodeoxyglucose F18 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Carcinoma, Non-Small-Cell Lung × L-BLP25 × Clear all
NCT00828009 2023-07-07

BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Eastern Cooperative Oncology Group

Phase 2 Completed
70 enrolled 10 charts
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡